Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: New $40M centre will solve cell therapy manufacturing challenges

by | Jan 15, 2016

It was huge news in Canada on Wednesday (January 13) when the Centre for Commercialization of Regenerative Medicine (CCRM) and GE Healthcare announced their partnership in the development of a new centre for advanced therapeutic cell technologies. GE Healthcare is providing CAD $20 million that the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) is matching dollar for dollar. The $40 million centre, to be built in Toronto, Ontario, and located at the MaRS West Tower, will develop solutions to solve manufacturing bottlenecks and make cell therapy affordable, available and scalable. Patients around the world will benefit from this initiative.

Canada’s Prime Minister, Justin Trudeau, traveled to Toronto to announce the government’s financial support of the new centre at an event for media, academics, industry, customers, business leaders and politicians. He was joined on the podium by two members of his cabinet, and the CEOs of CCRM and GE Canada.

 

 

Our regular feature, Right Turn, appears every Friday and we invite you to submit your own blog to info(at)ccrm.ca. We encourage you to be creative and use the right (!) side of your brain. We dare you to make us laugh! Right Turn features cartoons, photos, videos and other content to amuse, educate and encourage discussion.

As always, we welcome your feedback in the comment section.

The following two tabs change content below.
Avatar photo
My Twitter profileMy Google+ profileMy LinkedIn profile

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.

Submit a Comment

Your email address will not be published. Required fields are marked *